People

Elran Haber, CEO of Therapix Biosciences, which is developing intranasal cannabinoid-based drugs, will step down "to pursue other professional opportunities" after the company concludes its search for "a permanent, US based Chief Executive Officer," the company said. Over the past year, the Israeli company has licensed both an intranasal cannabinoid formulation … [Read more...] about Therapix Biosciences to look for US-based CEO

Arikayce inhaled amikacin deveoper Insmed Incorporated has announced the appointments of Paolo Tombesi as Chief Financial Officer, Paul Streck as Chief Medical Officer, and Eugene Sullivan as Chief Product Strategy Officer. Tombesi was most recently VP and Chief Financial and Administrative Officer of Novartis Pharmaceuticals Corporation, and Streck was most … [Read more...] about Insmed announces management appointments

Inhaled drug developer Pulmatrix has announced the appointment of former Sunovion Respiratory and CNS Business Unit Head Ted Raad as Chief Business Officer. Raad was most recently Chief Commercial Officer at Option Care, the home infusion services subsidiary of Walgreens. Pulmatrix CEO Robert Clarke said, "Ted is a proven leader in the commercial development of … [Read more...] about Pulmatrix appoints Ted Raad as Chief Business Officer

Digital health company Cohero Health has announced the appointment of Joe Condurso as CEO. Cohero and its partner Presspart introduced their eMDI smart inhaler system at DDL in 2016. Condurso was most recently CEO of PatientSafe Solutions and previously worked at CareFusion (now Becton Dickinson) and a number of other medical companies over a 30-year … [Read more...] about Cohero announces the appointment of Joe Condurso as CEO

Milestone Pharmaceuticals has announced the appointment of Joseph G. Oliveto as President and CEO. Oliveto, who was most recently CEO of Galleon Pharmaceuticals and previously served as President and CEO of Chelsea Therapeutics, is replacing company founder Phillippe Douville, who is now Chief Scientific Officer. Milestone's lead candidate, etripamil is an … [Read more...] about Milestone Pharmaceuticals appoints Joseph G. Oliveto as President and CEO

Intranasal drug developer Impel NeuroPharma has announced the appointment of former MAP Pharmaceuticals President and CEO Timothy S. Nelson as Independent Director of the Board of Directors. Nelson led MAP Pharmaceuticals when it was acquired by Allergan and served as Chairman of the Board of Civitas Therapeutics when that company was acquired by Acorda. MAP … [Read more...] about Timothy S. Nelson joins the board of Impel NeuroPharma

Lovelace Biomedical, a not-for-profit research organization which offers inhalation toxicology and other services for inhaled drug development, has announced the appointment of Larry Mallis as Director of Bioanalytical Operations. Mallis was most recently Director of Bioanalytical Services as Frontage Laboratories and was previously Director of Scientific Services … [Read more...] about Larry Mallis joins Lovelace Biomedical as Director of Bioanalytical Operations

OptiNose has announced that Keith A. Goldan has joined the company as Chief Financial Officer. Goldan was most recently Senior VP and CFO of Fibrocell and previously served as CFO at NuPathe, PuriCore (now Realm Therapeutics), and Biosyn. The announcement comes a few months after the company announced the appointment of Tom Gibbs as Chief Commercial Officer. In … [Read more...] about OptiNose appoints Keith A. Goldan as CFO